 LONDON--BUSINESS WIRE--Curaleaf International the Company part of Curaleaf Holdings CNSX:CURA, Europes largest vertically integrated cannabis company, is pleased to announce that Chief Scientific Officer, Dr Barbara Pacchetti will present research on one clinical study and three preclinical studies at a leading conference on medical cannabis on 21-22 October 2022. 